Cargando…
Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein
The major vault protein is the main component on multimeric vault particles, that are likely to play an essential role in normal cell physiology and to be associated with multidrug resistance of tumour cells. In order to unravel the function of vaults and their putative contribution to multidrug res...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364164/ https://www.ncbi.nlm.nih.gov/pubmed/11953829 http://dx.doi.org/10.1038/sj.bjc.6600159 |
_version_ | 1782153885112074240 |
---|---|
author | Scheffer, G L Reurs, A W Jutten, B Beiboer, S H W van Amerongen, R Schoester, M Wiemer, E A C Hoogenboom, H R Scheper, R J |
author_facet | Scheffer, G L Reurs, A W Jutten, B Beiboer, S H W van Amerongen, R Schoester, M Wiemer, E A C Hoogenboom, H R Scheper, R J |
author_sort | Scheffer, G L |
collection | PubMed |
description | The major vault protein is the main component on multimeric vault particles, that are likely to play an essential role in normal cell physiology and to be associated with multidrug resistance of tumour cells. In order to unravel the function of vaults and their putative contribution to multidrug resistance, specific antibodies are invaluable tools. Until now, only conventional major vault protein-reactive murine monoclonal antibodies have been generated, that are most suitable for immunohistochemical analyses. The phage display method allows for selection of human antibody fragments with potential use in clinical applications. Furthermore, cDNA sequences encoding selected antibody fragments are readily identified, facilitating various molecular targeting approaches. In order to obtain such human Fab fragments recognising major vault protein we used a large non-immunized human Fab fragment phage library. Phages displaying major vault protein-reactive Fabs were obtained through several rounds of selection on major vault protein-coated immunotubes and subsequent amplification in TG1 E coli bacteria. Eventually, one major vault protein-reactive clone was selected and further examined. The anti-major vault protein Fab was found suitable for immunohistochemical and Western blot analysis of tumour cell lines and human tissues. BIAcore analysis showed that the binding affinity of the major vault protein-reactive clone almost equalled that of the murine anti-major vault protein Mabs. The cDNA sequence of this human Fab may be exploited to generate an intrabody for major vault protein-knock out studies. Thus, this human Fab fragment should provide a valuable tool in elucidating the contribution(s) of major vault protein/vaults to normal physiology and cellular drug resistance mechanisms. British Journal of Cancer (2002) 86, 954–962. DOI: 10.1038/sj/bjc/6600159 www.bjcancer.com © 2002 Cancer Research UK |
format | Text |
id | pubmed-2364164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23641642009-09-10 Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein Scheffer, G L Reurs, A W Jutten, B Beiboer, S H W van Amerongen, R Schoester, M Wiemer, E A C Hoogenboom, H R Scheper, R J Br J Cancer Experimental Therapeutics The major vault protein is the main component on multimeric vault particles, that are likely to play an essential role in normal cell physiology and to be associated with multidrug resistance of tumour cells. In order to unravel the function of vaults and their putative contribution to multidrug resistance, specific antibodies are invaluable tools. Until now, only conventional major vault protein-reactive murine monoclonal antibodies have been generated, that are most suitable for immunohistochemical analyses. The phage display method allows for selection of human antibody fragments with potential use in clinical applications. Furthermore, cDNA sequences encoding selected antibody fragments are readily identified, facilitating various molecular targeting approaches. In order to obtain such human Fab fragments recognising major vault protein we used a large non-immunized human Fab fragment phage library. Phages displaying major vault protein-reactive Fabs were obtained through several rounds of selection on major vault protein-coated immunotubes and subsequent amplification in TG1 E coli bacteria. Eventually, one major vault protein-reactive clone was selected and further examined. The anti-major vault protein Fab was found suitable for immunohistochemical and Western blot analysis of tumour cell lines and human tissues. BIAcore analysis showed that the binding affinity of the major vault protein-reactive clone almost equalled that of the murine anti-major vault protein Mabs. The cDNA sequence of this human Fab may be exploited to generate an intrabody for major vault protein-knock out studies. Thus, this human Fab fragment should provide a valuable tool in elucidating the contribution(s) of major vault protein/vaults to normal physiology and cellular drug resistance mechanisms. British Journal of Cancer (2002) 86, 954–962. DOI: 10.1038/sj/bjc/6600159 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-03-18 /pmc/articles/PMC2364164/ /pubmed/11953829 http://dx.doi.org/10.1038/sj.bjc.6600159 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Experimental Therapeutics Scheffer, G L Reurs, A W Jutten, B Beiboer, S H W van Amerongen, R Schoester, M Wiemer, E A C Hoogenboom, H R Scheper, R J Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein |
title | Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein |
title_full | Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein |
title_fullStr | Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein |
title_full_unstemmed | Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein |
title_short | Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein |
title_sort | selection and characterisation of a phage-displayed human antibody (fab) reactive to the lung resistance-related major vault protein |
topic | Experimental Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364164/ https://www.ncbi.nlm.nih.gov/pubmed/11953829 http://dx.doi.org/10.1038/sj.bjc.6600159 |
work_keys_str_mv | AT scheffergl selectionandcharacterisationofaphagedisplayedhumanantibodyfabreactivetothelungresistancerelatedmajorvaultprotein AT reursaw selectionandcharacterisationofaphagedisplayedhumanantibodyfabreactivetothelungresistancerelatedmajorvaultprotein AT juttenb selectionandcharacterisationofaphagedisplayedhumanantibodyfabreactivetothelungresistancerelatedmajorvaultprotein AT beiboershw selectionandcharacterisationofaphagedisplayedhumanantibodyfabreactivetothelungresistancerelatedmajorvaultprotein AT vanamerongenr selectionandcharacterisationofaphagedisplayedhumanantibodyfabreactivetothelungresistancerelatedmajorvaultprotein AT schoesterm selectionandcharacterisationofaphagedisplayedhumanantibodyfabreactivetothelungresistancerelatedmajorvaultprotein AT wiemereac selectionandcharacterisationofaphagedisplayedhumanantibodyfabreactivetothelungresistancerelatedmajorvaultprotein AT hoogenboomhr selectionandcharacterisationofaphagedisplayedhumanantibodyfabreactivetothelungresistancerelatedmajorvaultprotein AT scheperrj selectionandcharacterisationofaphagedisplayedhumanantibodyfabreactivetothelungresistancerelatedmajorvaultprotein |